Skip to Main Content
Skip Nav Destination






(jem SITE a been)

Brand Names: US

  • Gemzar [DSC]
  • Infugem

Therapeutic Category

  • Antineoplastic Agent, Antimetabolite (Pyrimidine Antagonist)

Medication Safety Issues

Sound-alike/look-alike issues:

Gemcitabine may be confused with gemtuzumab

Gemzar may be confused with Zinecard

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.

Administration issues:

Multiple concentrations: Gemcitabine is available in multiple formulations and concentrations; verify product and concentration prior to admixture to assure appropriate dose preparation.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal